Pre-Conference Day, Tuesday October 22, 2024

4:00pm - 5:30pm | Speed Learning

In this quick-fire session, you have the opportunity to choose a table, each hosted by a peer leveraging spatial biology tools who will lead the conversation on one of these topics, then move on to the next, allowing you to discuss ideas in each area.

Some of the topics include:

  • Integrating different omics technologies to supercharge different drug development workflows
  • Working and collaborating with different functions with differing levels of expertise to effectively utilise spatial biology tools
  • Picking the right technology – how do you go about doing this, and how does it change depending on your scientific question?
  • Discussing best practices and troubleshooting strategies to overcome barriers with data quality and size when implementing AI

Shih-Ying Wu-Senior Advisor - Data Science & Bioinformatics, Eli Lilly & Co.

Winnie Tam-Scientific Director, Head of Precision Medicine Immunology Translation Research, AbbVie

6:00pm - 8:00pm | News & Brews in Partnership with Roche

Launching Companion Diagnostics into Space

Welcome to Roche News & Brews, an exclusive event series providing leaders in pharma and biotech opportunities to explore the latest innovations in technologies, facilitating the advancement of Spatial Biology.

 

Translating Spatial Biology into Improved Patient Diagnosis & Treatment: CDx-Dependent & Independent Pathways

·      Spatial biology is increasingly used to discover biomarkers with potential relevance to medicine, but it also can play a crucial role in Dx/CDx assay optimization and lead to new and improved assays for routine use in the clinic

·      Considerations to incorporate digital and computational pathology early in the IVD assay development process to improve likelihood of success

·      How Roche Diagnostics Solutions aims to empower early concept development to IVD creation, backed by digital and computational pathology, with the goal of successful assay commercialization and clinical implementation

Keith Wharton - Global Medical Affairs Leader - Pathology, Clinical Development & Medical Affairs, Oncology, Pathology and Genetics, Roche Diagnostics

Tim Ritty - Senior Marketing Manager - Clinical Research & Development Strategy, Roche Diagnostics

*Attendance is free for delegates but is subject to approval and by invitation only